google-site-verification: googlec7193c3de77668c9.html

Investigational drug delivers mixed results for uncontrolled blood pressure

[
The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, a protein that turns into the hormone that regulates blood pressure—caused a significant and sustained drop in angiotensinogen but its impact on blood pressure was less clear, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).


Source link

Advertisements

See also  Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

Check Also

Gut immune cells sustain pain even without inflammation through newly identified signaling pathway

[ PGP9.5+ fibers (green) and CX3CR1+ macrophages (magenta) in the colons of vehicle- and DSS-treated …

Researchers identify connection between pulmonary hypertension and cognitive impairment

[ Stephen Chan, M.D., Ph.D., and a team of Pitt and UPMC researchers identified brain …

Spinning, moving sensations differ from dizziness, expert explains

[ Credit: CC0 Public Domain Vertigo is a sensation that either you or your surroundings, …

Leave a Reply

Available for Amazon Prime